Suppr超能文献

2014-2020 年波士顿无家可归者队列中与丙型肝炎治疗持续病毒学应答相关的因素。

Factors Associated with Sustained Virologic Response to Hepatitis C Treatment in a Homeless-Experienced Cohort in Boston, 2014-2020.

机构信息

Institute for Research, Quality, and Policy in Homeless Health Care, Boston Health Care for the Homeless Program, Boston, MA, USA.

Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.

出版信息

J Gen Intern Med. 2023 Mar;38(4):865-872. doi: 10.1007/s11606-022-07778-w. Epub 2022 Sep 20.

Abstract

BACKGROUND

Engaging people experiencing homelessness or unstable housing in hepatitis C virus (HCV) treatment is critical to achieving HCV elimination.

OBJECTIVE

To describe HCV treatment outcomes, including factors associated with retention through the treatment cascade, for a cohort of individuals treated in a homeless health center in Boston.

DESIGN

Retrospective cohort study.

PARTICIPANTS

All individuals who initiated HCV treatment with Boston Health Care for the Homeless Program's HCV treatment program between January 2014 and March 2020 (N = 867).

OUTCOME MEASURES

The primary outcome was sustained virologic response (SVR), defined as an HCV ribonucleic acid (RNA) level ≤ 15 IU/mL at least 12 weeks after treatment completion. We used multivariable logistic regression to examine the association between baseline variables and SVR. Process-oriented outcomes included treatment completion, assessment for SVR, and achievement of SVR.

RESULTS

Of 867 individuals who started HCV treatment, 796 (91.8%) completed treatment, 678 (78.2%) were assessed for SVR, and 607 (70.0%) achieved SVR. In adjusted analysis, residing in stable housing (OR 3.83, 95% CI 1.85-7.90) and age > 45 years old (OR 1.53, 95% CI 1.04-2.26) were associated with a greater likelihood of achieving SVR. Recent drug use (OR 0.63, 95% CI 0.41-0.95) was associated with a lower likelihood of SVR. Age, housing status, and drug use status impacted retention at every step in the treatment cascade.

CONCLUSION

A large proportion of homeless-experienced individuals engaging in HCV treatment in a homeless health center achieved SVR, but enhanced approaches are needed to engage and retain younger individuals, those with recent or ongoing substance use, or those experiencing homelessness or unstable housing. Efforts to achieve HCV elimination in this population should consider the complex and overlapping challenges experienced by this population and aim to address the fundamental harm of homelessness itself.

摘要

背景

让无家可归或住房不稳定的人参与丙型肝炎病毒 (HCV) 治疗对于实现 HCV 消除至关重要。

目的

描述 HCV 治疗结果,包括与治疗级联中保留相关的因素,该研究纳入了在波士顿一家无家可归者健康中心接受治疗的个体队列。

设计

回顾性队列研究。

参与者

所有于 2014 年 1 月至 2020 年 3 月期间在波士顿无家可归者医疗保健项目 HCV 治疗项目中开始 HCV 治疗的个体(N=867)。

结局指标

主要结局是持续病毒学应答 (SVR),定义为治疗完成后至少 12 周时 HCV 核糖核酸 (RNA) 水平≤15IU/mL。我们使用多变量逻辑回归来检验基线变量与 SVR 之间的关系。面向过程的结局包括治疗完成、SVR 评估和 SVR 达标。

结果

在开始 HCV 治疗的 867 名个体中,796 名(91.8%)完成了治疗,678 名(78.2%)接受了 SVR 评估,607 名(70.0%)实现了 SVR。在调整后的分析中,居住在稳定住房中(比值比 3.83,95%置信区间 1.85-7.90)和年龄>45 岁(比值比 1.53,95%置信区间 1.04-2.26)与 SVR 达标更相关。近期药物使用(比值比 0.63,95%置信区间 0.41-0.95)与 SVR 可能性降低相关。年龄、住房状况和药物使用状况在治疗级联的每一步都影响保留率。

结论

在无家可归者健康中心参与 HCV 治疗的大量无家可归经历者实现了 SVR,但需要采取强化措施来吸引和留住年轻个体、近期或持续使用药物的个体、或无家可归或住房不稳定的个体。在这一人群中实现 HCV 消除的努力应考虑到该人群所经历的复杂和重叠的挑战,并旨在解决无家可归本身所带来的根本危害。

相似文献

1
Factors Associated with Sustained Virologic Response to Hepatitis C Treatment in a Homeless-Experienced Cohort in Boston, 2014-2020.
J Gen Intern Med. 2023 Mar;38(4):865-872. doi: 10.1007/s11606-022-07778-w. Epub 2022 Sep 20.
2
Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston.
Int J Drug Policy. 2019 Oct;72:129-137. doi: 10.1016/j.drugpo.2019.03.017. Epub 2019 Apr 6.
3
Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston.
Clin Infect Dis. 2023 Jul 5;77(1):46-55. doi: 10.1093/cid/ciad127.
6
Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy.
JAMA Netw Open. 2023 Sep 5;6(9):e2335715. doi: 10.1001/jamanetworkopen.2023.35715.
7

引用本文的文献

1
Racial and Sociodemographic Disparities in Hepatitis C Treatment at an Urban Academic Medical Center, 2018-2023.
Open Forum Infect Dis. 2025 Jun 13;12(6):ofaf312. doi: 10.1093/ofid/ofaf312. eCollection 2025 Jun.
2
Implementation of Site-Specific Hepatitis C Virus Treatment Workflows for Vulnerable, High-Risk Populations: A Prospective Single-Arm Trial.
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251330622. doi: 10.1177/21501319251330622. Epub 2025 Mar 31.
3
A novel multisite model to facilitate hepatitis C virus elimination in people experiencing homelessness.
JHEP Rep. 2024 Aug 12;6(11):101183. doi: 10.1016/j.jhepr.2024.101183. eCollection 2024 Nov.

本文引用的文献

2
Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020.
Hepatol Commun. 2021 May 3;5(6):911-922. doi: 10.1002/hep4.1731. eCollection 2021 Jun.
6
Individual and network factors associated with HCV treatment uptake among people who inject drugs.
Int J Drug Policy. 2020 Apr;78:102714. doi: 10.1016/j.drugpo.2020.102714. Epub 2020 Mar 2.
8
Loss to follow-up: A significant barrier in the treatment cascade with direct-acting therapies.
J Viral Hepat. 2020 Mar;27(3):243-260. doi: 10.1111/jvh.13228. Epub 2019 Dec 2.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验